Abstract
Purpose: Kava is a traditional Pacific beverage made from the root of Piper methysticum . It is mainly used for its sedative properties due to lipophilic lactones called kavalactones. Various preparations or medications made from this plant can be purchased via the internet. Kava action mechanisms include cell membrane stabilisation, inhibition of intracellular Ca 2+ increase and enzyme inactivation. Chronic or heavy kava consumption results in the skin taking on a scaly aspect. Biologically, an isolated increase in serum gamma-glutamyltransferase is apparent. Cases of sudden death after heavy kava sessions have occurred in Australia, and nine cases in New Caledonia were reported by our forensic laboratory during the 2000−mid-2013 period. No clear explanation has been given. We describe the possible action mechanism. Methods: We monitored 116 heavy kava drinkers. A multiple-probe drug cocktail was used on six other volunteers, all heavy and chronic kava drinkers, before and after kava abstinence to carry out CYP450 phenotyping. Results: The heavy chronic drinkers showed an isolated increase in GGT without any biological or clinical abnormality other than scaly skin. With the multiple-probe drug cocktail an inhibition of the CYP1A2 isoenzyme was demonstrated. In kava dermopathy a lack of epithelial nitric oxide production leading to an increased S-nitroso-glutathione degradation by the epithelial gamma-glutamyltransferase should be considered. Conclusions: As there are close structural and functional similarities between nitric oxide synthase (NOS) and CYP1A2, and as we have formerly demonstrated that kava inhibits CYP1A2, an inhibition of NOS in chronic kava drinkers must be studied to see if ichthyosis can be explained, and if high blood GGT level is a reflection of epithelial cell GGT activity. Furthermore, a decrease in NO bioavailability can cause myocardial and vascular dysfunctions and hypercoagulability, leading to acute coronary syndrome or ischemic stroke. This mechanism should be explored in cases of “post-kava session sudden death”.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.